latest news in companies
Alphabet Sets New Retail Standard Enabling AI Agents to Shop Autonomously
Mountain View, Monday, 12 January 2026.
On January 10, Alphabet introduced the Universal Commerce Protocol, a critical infrastructure shift enabling AI agents to autonomously discover and purchase inventory for consumers across global digital storefronts.
Meta Appoints Dina Powell McCormick President to Strengthen AI and Government Ties
Menlo Park, Monday, 12 January 2026.
Leveraging deep political and financial ties, Meta appoints former Trump advisor Dina Powell McCormick as president to secure global backing for its ambitious AI infrastructure buildout.
NANO Nuclear and Ameresco Collaborate to Deploy Portable Microreactors for Federal and Commercial Use
New York, Monday, 12 January 2026.
This January 12, 2026 agreement integrates portable microreactors into federal infrastructure, supporting Ameresco’s goal to reduce carbon emissions by 500 million metric tons by 2050 through advanced nuclear technology.
Moderna Surpasses 2025 Revenue Forecasts and Outlines 2026 Growth Strategy
San Francisco, Monday, 12 January 2026.
On January 12, 2026, Moderna (MRNA) announced it exceeded its fiscal guidance for 2025, reporting unaudited revenue of approximately $1.9 billion—$100 million above previous projections. Speaking at the J.P. Morgan Healthcare Conference, the company highlighted a disciplined approach to capital allocation, having reduced operating expenses by $200 million while securing a solid cash balance of $8.1 billion. This financial stability underpins Moderna’s 2026 strategy, which targets up to 10% revenue growth driven by anticipated regulatory approvals for its influenza and combination flu/COVID vaccines. Beyond immediate commercial targets, the market is closely watching for pivotal trial data in oncology and rare diseases expected later this year. These developments suggest Moderna is successfully pivoting from its pandemic-era reliance, aiming for sustainable growth through a diversified mRNA pipeline.
